BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32387251)

  • 21. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
    Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
    Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
    Malan D; Zhang M; Stallmeyer B; Müller J; Fleischmann BK; Schulze-Bahr E; Sasse P; Greber B
    Basic Res Cardiol; 2016 Mar; 111(2):14. PubMed ID: 26803770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2.
    Bodi I; Sorge J; Castiglione A; Glatz SM; Wuelfers EM; Franke G; Perez-Feliz S; Koren G; Zehender M; Bugger H; Seemann G; Brunner M; Bode C; Odening KE
    Europace; 2019 Jul; 21(7):1126-1138. PubMed ID: 30938413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.
    Stutzman MJ; Gao X; Kim M; Ye D; Zhou W; Tester DJ; Giudicessi JR; Shannon K; Ackerman MJ
    Heart Rhythm; 2023 May; 20(5):709-717. PubMed ID: 36731785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overlap Arrhythmia Syndromes Resulting from Multiple Genetic Variations Studied in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Treat JA; Pfeiffer R; Barajas-Martinez H; Goodrow RJ; Bot C; Haedo RJ; Knox R; Cordeiro JM
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inward Rectifier Potassium Channels (Kir2.x) and Caveolin-3 Domain-Specific Interaction: Implications for Purkinje Cell-Dependent Ventricular Arrhythmias.
    Vaidyanathan R; Van Ert H; Haq KT; Morotti S; Esch S; McCune EC; Grandi E; Eckhardt LL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005800. PubMed ID: 29326130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.
    Lan H; Xu Q; El-Battrawy I; Zhong R; Li X; Lang S; Cyganek L; Borggrefe M; Zhou X; Akin I
    Front Pharmacol; 2020; 11():554422. PubMed ID: 33154722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-QT syndrome-associated caveolin-3 mutations differentially regulate the hyperpolarization-activated cyclic nucleotide gated channel 4.
    Motloch LJ; Larbig R; Darabi T; Reda S; Motloch KA; Wernly B; Lichtenauer M; Gebing T; Schwaiger A; Zagidullin N; Wolny M; Hoppe UC
    Physiol Int; 2017 Jun; 104(2):130-138. PubMed ID: 28648120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple mechanisms underlie increased cardiac late sodium current.
    Kroncke BM; Yang T; Roden DM
    Heart Rhythm; 2019 Jul; 16(7):1091-1097. PubMed ID: 30677491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of acquired long QT syndrome in patients with propionic academia.
    Bodi I; Grünert SC; Becker N; Stoelzle-Feix S; Spiekerkoetter U; Zehender M; Bugger H; Bode C; Odening KE
    Heart Rhythm; 2016 Jun; 13(6):1335-45. PubMed ID: 26854997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study.
    Miller JA; Moise N; Weinberg SH
    Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H179-H197. PubMed ID: 36487185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.
    Wu J; Wang X; Chung YY; Koh CH; Liu Z; Guo H; Yuan Q; Wang C; Su S; Wei H
    PLoS One; 2017; 12(1):e0168435. PubMed ID: 28056022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells.
    Yoshinaga D; Baba S; Makiyama T; Shibata H; Hirata T; Akagi K; Matsuda K; Kohjitani H; Wuriyanghai Y; Umeda K; Yamamoto Y; Conklin BR; Horie M; Takita J; Heike T
    Stem Cell Reports; 2019 Aug; 13(2):394-404. PubMed ID: 31378668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hERG mutation E1039X produced a synergistic lesion on I
    Wu J; Mizusawa Y; Ohno S; Ding WG; Higaki T; Wang Q; Kohjitani H; Makiyama T; Itoh H; Toyoda F; James AF; Hancox JC; Matsuura H; Horie M
    Sci Rep; 2018 Feb; 8(1):3129. PubMed ID: 29449639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human-induced pluripotent stem cell-derived cardiomyocytes have limited I
    Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
    JRSM Cardiovasc Dis; 2019; 8():2048004019854919. PubMed ID: 31217965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
    J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.